Report Detail
Brain Monitoring Devices Global Market - Forecast to 2026
- RnM4214915 |
- 25 September, 2020 |
- Global |
- 514 Pages |
- IQ4I Research & Consultancy |
- Other
Brain monitoring devices are used to monitor the electrical and neuronal activity of the patient’s head which helps to diagnose various neuronal conditions, sleep disorders, brain tumors, and others. The brain monitoring devices market is expected to grow at mid single digit CAGR of from 2019 to 2026 to reach $8,855.9 million by 2026. Growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, growing healthcare spending in brain monitoring are driving the market growth. However, the high cost of complex brain monitoring devices, lack of skilled neurologists and neurosurgeons, stringent regulatory approvals for products, unfavorable reimbursement policies are restraining the market growth.
The brain monitoring devices global market segmented based on products, applications, modality, and end-users. The market by product is segmented into electroencephalography (EEG), magnetoencephalography (MEG), Intracranial Pressure (ICP) monitors, Transcranial Doppler Sonography (TCD), Electromyograph (EMG), Cerebral Oximeters, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), and sleep monitoring devices. According to IQ4I research, MRI accounted for the largest revenue in 2019 due to MRI is a premium and sensitive imaging test for brain imaging, used in routine clinical practice. EEG segment is expected to grow at high single digit CAGR from 2019 to 2026.
The electroencephalography devices market is further segmented into 8-Channel EEG, 21-Channel EEG, 25-Channel EEG, 32-Channel EEG, 40-Channel EEG, and multi-channel EEG based on the number of channels. Among them, the 32-Channel EEG devices segment contributed the largest revenue in 2019 and is expected to grow at a strong double digit CAGR from 2019 to 2026. Increasing incidence of neurological diseases, increasing demand by neurologists and patients for advanced monitoring techniques are the factors driving the market growth.
The MRI devices market is further segmented into Low and middle field MRI, High-field MRI, and Very high field MRI based on technology. Among these, the high field MRI devices contributed the largest revenue in 2019 and are expected to grow at mid single digit CAGR from 2019 to 2026 due to accuracy and efficiency to offer a spatial resolution. Very high field MRI is expected to grow at a high single digit CAGR from 2019 to 2026.
The CT devices market is segmented into Low slice CT, Medium slice CT and High slice CT based on technology. Among the segments, medium slice CT devices generated the largest revenue in 2019 and are expected to grow at a mid single digit CAGR from 2019 to 2026. High slice CT is expected to grow at high single digit CAGR from 2019 to 2026 due to the rising adoption of CT for diagnostic procedures and the expanded application horizons of CT technology.
The brain monitoring devices market is further segmented into neurodegenerative disorders, neurovascular diseases, Traumatic brain injury, brain tumor, sleep disorders, psychiatric behavioral disorders, and others based on application. Among these, Sleep disorders accounted for the largest revenue in 2019 and are expected to grow at a CAGR of low single digit from 2019 to 2026. Traumatic brain injury is expected to grow at a high single digit CAGR from 2019 to 2026 due to the growing incidence of TBI’s across the globe due to rise in accidence cases, leading to the high demand for the management of these cases-which requires the intensive use of brain monitoring devices.
Neurodegenerative disorders are further segmented into Alzheimer’s, Parkinson’s disease, Epilepsy, and others (Huntington’s disease) based on diseases. Among these, Epilepsy accounted for the largest revenue in 2019. Alzheimer’s is expected to grow at a mid single digit CAGR from 2019 to 2026.
Sleep disorders are further segmented into insomnia, sleep apnea, sleep movement disorders, and others (hypersomnia). Among these, Sleep apnea accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026.
Psychiatric behavioral disorders are further segmented into Schizophrenia, Bipolar disorders, and others (Depression, Autism & Dyslexia). Among these, Schizophrenia accounted for the largest revenue in 2019 and bipolar disorder is expected to grow at mid single digit CAGR from 2019 to 2026.
Other applications are further segmented into surgery, hydrocephalus, and others. Among these, surgery accounted for the largest revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.
The brain monitoring devices segmented into stationary, portable, and wearable based on portability. Among these, stationary accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. The portable segment is expected to grow at mid single digit CAGR 2019 to 2026.
The brain monitoring devices market based on end-user is segmented into hospitals, home care, ambulatory surgical centers and clinics, diagnostic laboratories, sleep centers, and others. Among these, the hospitals are accounted for the largest revenue in 2019 and are expected to grow at mid single digit CAGR from 2019 to 2026.
The brain monitoring devices market based on region is segmented into North-America, Europe, APAC and the Rest of the world. North America accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026. APAC is expected to grow at high single digit CAGR from 2019 to 2026.
Major players in brain monitoring device market are Medtronic, PLC (Ireland), Integra Lifesciences (U.S.), Masimo Corporation (Switzerland), GE Healthcare (U.S.), Koninklijke Philips N.V. (The Netherlands), Nihon Kohden Corporation (Japan), Natus medical Incorporated (U.S.), Siemens Healthineers (Germany), Resmed, Inc. (U.S.) and Vyaire Medical, Inc. (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America (U.S. and Rest of N.A.)
• Europe (Germany, France, U.K. and Rest of E.U.)
• Asia-Pacific (Japan, China, India and Rest of APAC)
• Rest of the World (RoW) (Brazil, Rest of Latin-America and the Middle East & Others)
1 EXECUTIVE SUMMARY 26
2 INTRODUCTION 31
- 2.1 KEY TAKEAWAYS 31
- 2.2 SCOPE OF THE REPORT 32
- 2.3 REPORT DESCRIPTION 32
- 2.4 MARKETS COVERED 35
- 2.5 STAKEHOLDERS 37
- 2.6 RESEARCH METHODOLOGY 37
- 2.6.1 MARKET SIZE ESTIMATION 39
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 41
- 2.6.3 SECONDARY SOURCES 42
- 2.6.4 PRIMARY SOURCES 42
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 43
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 44
- 2.6.7 ASSUMPTIONS 44
3 MARKET ANALYSIS 46
- 3.1 INTRODUCTION 46
- 3.2 MARKET SEGMENTATION 47
- 3.3 FACTORS INFLUENCING MARKET 49
- 3.3.1 DRIVERS AND OPPORTUNITIES 50
- 3.3.1.1 Growing incidence and prevalence of neurological disorders 50
- 3.3.1.2 Rising awareness about neurodegenerative disorders 50
- 3.3.1.3 Growing healthcare spending 52
- 3.3.1.4 Technological advancements in brain monitoring devices 53
- 3.3.1.5 Increasing focus on minimally invasive and non-invasive brain activity
monitoring procedures 54
- 3.3.1.6 Extended application of devices in clinical trials 56
- 3.3.1 DRIVERS AND OPPORTUNITIES 50
- 3.3.2 RESTRAINTS & THREATS 56
- 3.3.2.1 The high cost of complex devices 56
- 3.3.2.2 Lack of skilled neurologists & neurosurgeons 57
- 3.3.2.3 Stringent regulations and legislations guiding the brain monitoring device manufacturers 58
- 3.3.2.4 Unfavorable reimbursement policies 59
- 3.4.1 BRAIN MONITORING MARKET SHARE ANALYSIS 60
- 3.4.2 EEG MARKET SHARE ANALYSIS 64
- 3.4.3 ICP MARKET SHARE ANALYSIS 66
- 3.4.4 TCD MARKET SHARE ANALYSIS 68
- 3.4.5 PSG MARKET SHARE ANALYSIS 70
- 3.4.6 CEREBRAL OXIMETER MARKET SHARE ANALYSIS 72
- 3.5.1 THE U.S. 74
- 3.5.2 EUROPE 75
- 3.5.3 CHINA 76
- 3.5.4 INDIA 77
- 3.5.5 JAPAN 78
- 3.6.1 DISSOLVABLE BRAIN IMPLANTS 79
- 3.6.2 DIFFUSED OPTICAL TOMOGRAPHY 80
- 3.6.3 ARTIFICIAL INTELLIGENCE 80
- 3.6.4 EAR ENCEPHALOGRAPHY (EAR-EEG) 81
- 3.6.5 FUNCTIONAL NEAR-INFRARED SPECTROSCOPY (FNIRS) 81
- 3.6.6 INTRACRANIAL ELECTROENCEPHLAOGRAPHY (IEEG)OR ECOG 82
- 3.6.7 MULTI-ELECTRODE ARRAY (MEA) 82
- 3.6.8 DIFFUSION TENSOR IMAGING TRACTOGRAPHY (DTI TRACTOGRAPHY) 83
NEW PRODUCT LAUNCH 87
- 3.9 BRAIN MONITORING DEVICES-ACQUISITION 88
- 3.10 BRAIN MONITORING DEVICES-DEALS 89
- 3.11 APPROVAL 93
- 3.12 PORTER’S FIVE FORCE ANALYSIS 94
- 3.12.1 THREAT OF NEW ENTRANTS 95
- 3.12.2 THREAT OF SUBSTITUTES 96
- 3.12.3 RIVALRY AMONG EXISTING COMPETITORS 96
- 3.12.4 BARGAINING POWER OF SUPPLIERS 96
- 3.12.5 BARGAINING POWER OF BUYERS 97
- 3.13 PATENT ANALYSIS 98
- 3.14 UNITS SOLD OF BRAIN MONITORING DEVICES 99
- 3.14.1 EEG DEVICES UNITS SOLD 99
- 3.14.2 ICP DEVICES UNITS SOLD 101
- 3.14.3 EMG DEVICES UNITS SOLD 103
- 3.14.4 CEREBRAL OXIMETER DEVICES UNITS SOLD 105
- 3.14.5 TCD DEVICES UNITS SOLD 107
- 3.14.6 PSG DEVICES UNITS SOLD 109
- 3.15 INSTALLED BASE OF BRAIN MONITORING DEVICES 111
- 3.15.1 EEG DEVICES INSTALLED BASE 111
- 3.15.2 ICP DEVICES INSTALLED BASE 113
- 3.15.3 EMG DEVICES INSTALLED BASE 115
- 3.15.4 CEREBRAL OXIMETER DEVICES INSTALLED BASE 117
- 3.15.5 TCD DEVICES INSTALLED BASE 119
- 3.15.6 PSG DEVICES INSTALLED BASE 121
4 BRAIN MONITORING DEVICES MARKET, BY PRODUCTS 123
- 4.1 INTRODUCTION 123
- 4.2 ELECTROENCEPHALOGRAPHY (EEG) DEVICES 127
- 4.2.1 BY PRODUCTS 130
- 4.2.1.1 8-Channel EEG 132
- 4.2.1.2 21-Channel EEG 133
- 4.2.1.3 25-Channel EEG 135
- 4.2.1.4 32-Channel EEG 136
- 4.2.1.5 40-Channel EEG 137
- 4.2.1.6 Multi-Channel EEG 139
- 4.2.1 BY PRODUCTS 130
- 4.3 MAGNETOENCEPHALOGRAPHY (MEG) DEVICES 141
- 4.4 INTRACRANIAL PRESSURE (ICP) MONITORS 143
- 4.5 TRANSCRANIAL DOPPLER DEVICES 146
- 4.6 ELECTROMYOGRAPH MACHINES (EMG) 149
- 4.7 CEREBRAL OXIMETERS 151
- 4.8 MAGNETIC RESONANCE IMAGING (MRI) DEVICES 156
- 4.8.1 BY TECHNOLOGY 159
- 4.8.1.1 Low and Middle Field MRI 161
- 4.8.1.2 High Field MRI 163
- 4.8.1.3 Very High Field MRI 165
- 4.8.1 BY TECHNOLOGY 159
- 4.9 COMPUTERIZED TOMOGRAPHY (CT) DEVICES 168
- 4.9.1 BY TECHNOLOGY 170
- 4.9.1.1 Low Slice CT 173
- 4.9.1.2 Medium Slice CT 175
- 4.9.1.3 High Slice CT 177
- 4.9.1 BY TECHNOLOGY 170
- 4.10 POSITRON EMISSION TOMOGRAPHY (PET) DEVICES 181
- 4.11 SLEEP MONITORING DEVICES 185
- 4.12 OTHERS 188
5 BRAIN MONITORING DEVICES GLOBAL MARKET, BY APPLICATIONS 190
- 5.1 INTRODUCTION 190
- 5.2 NEURODEGENERATIVE DISORDERS 192
- 5.2.1 ALZHEIMER’S DISEASE (DEMENTIA) 196
- 5.2.2 PARKINSON’S DISEASE 199
- 5.2.3 EPILEPSY 202
- 5.2.4 OTHERS (HUNTINGTON’S DISEASE) 205
- 5.2.5 NEUROVASCULAR DISEASE 207
- 5.3 BRAIN TUMOR 212
- 5.4 SLEEP DISORDERS 215
- 5.4.1 INSOMNIA 218
- 5.4.2 SLEEP APNEA 220
- 5.4.3 SLEEP MOVEMENT DISORDERS 221
- 5.4.4 OTHERS (HYPERSOMNIA) 223
- 5.5 PSYCHIATRIC BEHAVIORAL DISORDERS 224
- 5.5.1 SCHIZOPHRENIA 227
- 5.5.2 BIPOLAR DISORDERS 229
- 5.5.3 OTHERS 230
- 5.6 OTHER APPLICATIONS 234
- 5.6.1 SURGERY 237
- 5.6.2 HYDROCEPHALUS 238
- 5.6.3 OTHERS 240
6 BRAIN MONITORING DEVICES MARKET, BY MODALITY 244
- 6.1 INTRODUCTION 244
- 6.2 STATIONARY BRAIN MONITORING DEVICES 247
- 6.3 PORTABLE BRAIN MONITORING DEVICES 249
- 6.4 WEARABLE BRAIN MONITORING DEVICES 251
7 BRAIN MONITORING DEVICES GLOBAL MARKET, BY END-USERS 253
- 7.1 INTRODUCTION 253
- 7.2 HOSPITALS 255
- 7.3 HOME CARE 258
- 7.4 AMBULATORY SURGICAL CENTERS AND CLINICS 261
- 7.5 DIAGNOSTIC LABORATORIES 263
- 7.6 SLEEP CENTERS 265
- 7.7 OTHER END-USERS 267
8 BRAIN MONITORING DEVICES MARKET BY REGION 271
- 8.1 INTRODUCTION 271
- 8.2 NORTH AMERICA 275
- 8.2.1 THE U.S. 300
- 8.2.2 REST OF NORTH AMERICA 304
- 8.3 EUROPE 309
- 8.3.1 GERMANY 335
- 8.3.2 FRANCE 339
- 8.3.3 U.K 343
- 8.3.4 REST OF EUROPE 347
- 8.4 APAC 351
- 8.4.1 JAPAN 377
- 8.4.2 CHINA 382
- 8.4.3 INDIA 386
- 8.4.4 REST OF APAC 390
- 8.5 ROW 394
- 8.5.1 BRAZIL 419
- 8.5.2 REST OF LATAM 424
- 8.5.3 MIDDLE EAST AND OTHERS 428
9 COMPETITIVE LANDSCAPE 432
- 9.1 INTRODUCTION 432
- 9.2 COLLABORATION, AGREEMENTS, AND PARTNERSHIPS 433
- 9.3 APPROVALS 437
- 9.4 NEW PRODUCT LAUNCH 440
- 9.5 OTHER DEVELOPMENTS 441
10 MAJOR PLAYER PROFILES 442
- 10.1 GE COMPANY 442
- 10.1.1 OVERVIEW 442
- 10.1.2 FINANCIALS 443
- 10.1.3 PRODUCT PORTFOLIO 447
- 10.1.4 KEY DEVELOPMENTS 447
- 10.1.5 BUSINESS STRATEGY 448
- 10.1.6 SWOT ANALYSIS 449
- 10.2 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 450
- 10.2.1 OVERVIEW 450
- 10.2.2 FINANCIALS 451
- 10.2.3 PRODUCT PORTFOLIO 455
- 10.2.4 KEY DEVELOPMENTS 455
- 10.2.5 BUSINESS STRATEGY 455
- 10.2.6 SWOT ANALYSIS 456
- 10.3 KONINKLIJKE PHILIPS N.V. 457
- 10.3.1 OVERVIEW 457
- 10.3.2 FINANCIALS 458
- 10.3.3 PRODUCT PORTFOLIO 461
- 10.3.4 KEY DEVELOPMENTS 462
- 10.3.5 BUSINESS STRATEGY 464
- 10.3.6 SWOT ANALYSIS 465
- 10.4 MASIMO CORPORATION 466
- 10.4.1 OVERVIEW 466
- 10.4.2 FINANCIALS 467
- 10.4.3 PRODUCT PORTFOLIO 469
- 10.4.4 KEY DEVELOPMENTS 470
- 10.4.5 BUSINESS STRATEGY 472
- 10.4.6 SWOT ANALYSIS 473
- 10.5 MEDTRONIC, PLC 474
- 10.5.1 OVERVIEW 474
- 10.5.2 FINANCIALS 475
- 10.5.3 PRODUCT PORTFOLIO 478
- 10.5.4 KEY DEVELOPMENTS 479
- 10.5.5 BUSINESS STRATEGY 480
- 10.5.6 SWOT ANALYSIS 481
- 10.6 NATUS MEDICAL INC.ORPORATED. 482
- 10.6.1 OVERVIEW 482
- 10.6.2 FINANCIALS 483
- 10.6.3 PRODUCT PORTFOLIO 486
- 10.6.4 KEY DEVELOPMENTS 488
- 10.6.5 BUSINESS STRATEGY 488
- 10.6.6 SWOT ANALYSIS 489
- 10.7 NIHON KOHEDEN CORPORATION. 490
- 10.7.1 OVERVIEW 490
- 10.7.2 FINANCIALS 491
- 10.7.3 PRODUCT PORTFOLIO 494
- 10.7.4 KEY DEVELOPMENTS 494
- 10.7.5 BUSINESS STRATEGY 495
- 10.7.6 SWOT ANALYSIS 496
- 10.8 RESMED INC. 497
- 10.8.1 OVERVIEW 497
- 10.8.2 FINANCIALS 498
- 10.8.3 PRODUCT PORTFOLIO 500
- 10.8.4 KEY DEVELOPMENTS 501
- 10.8.5 BUSINESS STRATEGY 501
- 10.8.6 SWOT ANALYSIS 502
- 10.9 SIEMENS HEALTHINEERS 503
- 10.9.1 OVERVIEW 503
- 10.9.2 FINANCIALS 504
- 10.9.3 PRODUCT PORTFOLIO 506
- 10.9.4 KEY DEVELOPMENTS 508
- 10.9.5 BUSINESS STRATEGY 508
- 10.9.6 SWOT ANALYSIS 510
- 10.10 VYAIRE MEDICAL, INC. 511
- 10.10.1 OVERVIEW 511
- 10.10.2 FINANCIALS 511
- 10.10.3 PRODUCT PORTFOLIO 512
- 10.10.4 KEY DEVELOPMENTS 512
- 10.10.5 BUSINESS STRATEGY 512
Summary:
Get latest Market Research Reports on Brain Monitoring Devices 17072020. Industry analysis & Market Report on Brain Monitoring Devices 17072020 is a syndicated market report, published as Brain Monitoring Devices Global Market - Forecast to 2026. It is complete Research Study and Industry Analysis of Brain Monitoring Devices 17072020 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
